Cancer
Malignant Esophageal Neoplasm
CI-CAN-00001127Explore in graph →
Top-level518 active trials6 approved drugs12 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001127Explore in graph →
Clinical trials
1,926 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (169)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01688908 | Efficacy of Endoscopy Screening on Esophageal Cancer in China (ESECC)(ESECC) | active not recruiting | N/A | 33,948 | Peking UniversityOTHER | 1 | Jan 23, 2018 | clinicaltrials |
| NCT03286920 | Effect of Postoperative Family Nutrition Mode on Weight/BMI of Patients With Esophageal Cancer | unknown | — | 600 | Peking University Cancer Hospital & InstituteOTHER | 1 | Jan 23, 2018 |
| clinicaltrials |
| NCT03366883 | Paclitaxel, Cisplatin,5-FU vs. Radiotherapy Plus Paclitaxel, Cisplatin as Preoperative Therapy for Locally Advanced ESC | unknown | Phase 3 | 420 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Jan 9, 2018 | clinicaltrials |
| NCT00848783 | Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers | terminated | Phase 2 | 8 | NYU Langone HealthOTHER | 1 | Jan 8, 2018 | clinicaltrials |
| NCT03126708 | Cetuximab in Combination With Paclitaxel Plus Cisplatin Versus Paclitaxel Plus Cisplatin Alone for the First-line Treatment of Metastatic Esophageal Squamous Cell Carcinoma | unknown | Phase 2 | 150 | Peking UniversityOTHER | 1 | Jan 4, 2018 | clinicaltrials |
| NCT03378869 | Perioperative Management and Outcomes of Minimally Invasive Esophagectomy | completed | — | 64 | National Taiwan University HospitalOTHER | 1 | Dec 20, 2017 | clinicaltrials |
| NCT01097304 | Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia | completed | Phase 2 | 36 | National Cancer Institute (NCI)NIH | 1 | Dec 19, 2017 | clinicaltrials |
| NCT03307941 | Assessment of Metabolic & Path Response w/ RCT & ImT Before Surgery in Locally Advanced Esoph and Gastro-esoph Jction CA(ARTEMIS-Eso) | withdrawn | Phase 1 / Phase 2 | 0 | Jules Bordet InstituteOTHER | 1 | Dec 19, 2017 | clinicaltrials |
| NCT01178944 | Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer | completed | Phase 2 | 35 | Roswell Park Cancer InstituteOTHER | 1 | Dec 13, 2017 | clinicaltrials |
| NCT00201747 | Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer | completed | Phase 2 | 80 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Dec 6, 2017 | clinicaltrials |
| NCT01808417 | NIR-Guided Sentinel Lymph-Node Mapping for Esophageal Cancer | completed | Phase 1 | 10 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 2, 2017 | clinicaltrials |
| NCT02545751 | SBRT Combined With Thymalfasin for Metastatic Esophageal Cancer | unknown | Phase 2 | 29 | Hangzhou Cancer HospitalOTHER | 1 | Nov 28, 2017 | clinicaltrials |
| NCT01582906 | A Survivorship Care Plan for Gynaecological Cancer Patients | completed | — | 150 | Royal Marsden NHS Foundation TrustOTHER | 1 | Nov 24, 2017 | clinicaltrials |
| NCT00666978 | Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking | completed | Phase 4 | 540 | Lisa Sanderson Cox, PhDOTHER | 1 | Nov 13, 2017 | clinicaltrials |
| NCT02157363 | POsitioning for Esophageal Cancer Resection(POETRI) | terminated | N/A | 47 | Technische Universität DresdenOTHER | 1 | Oct 20, 2017 | clinicaltrials |
| NCT03273647 | Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma With Positive Circumstantial Resection Margin | unknown | Phase 3 | 60 | Fudan UniversityOTHER | 0 | Oct 19, 2017 | clinicaltrials |
| NCT03314311 | Rehabilitative Strategies Following Oesophageal Cancer(ReStOre) | completed | N/A | 44 | University of Dublin, Trinity CollegeOTHER | 1 | Oct 19, 2017 | clinicaltrials |
| NCT02653521 | The Clinical Physics Research of Image Guided Adaptive Radiation Therapy for Esophagus Cancer | unknown | N/A | 80 | Sun Yat-sen UniversityOTHER | 1 | Oct 11, 2017 | clinicaltrials |
| NCT02424864 | 4D FDG PET in Esophageal Cancer | completed | N/A | 54 | The Netherlands Cancer InstituteOTHER | 1 | Sep 28, 2017 | clinicaltrials |
| NCT01065818 | Early Prediction of Pathology Response of Chemoradiotherapy With FLT PET | terminated | N/A | 6 | Columbia UniversityOTHER | 1 | Sep 26, 2017 | clinicaltrials |
| NCT02850172 | Effects of a "Walk, Eat, & Breathe" Nursing Intervention For Patients With Esophageal Cancer | unknown | N/A | 144 | National Taiwan University HospitalOTHER | 1 | Sep 26, 2017 | clinicaltrials |
| NCT00137852 | Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal Cancer | completed | Phase 2 | 35 | Dana-Farber Cancer InstituteOTHER | 1 | Sep 20, 2017 | clinicaltrials |
| NCT02384811 | Phase II Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy for Esophageal Squamous Cell Carcinoma | unknown | Phase 2 | 70 | Fudan UniversityOTHER | 1 | Sep 7, 2017 | clinicaltrials |
| NCT03273686 | Efficacy of Nasogastric Tube Application in Postoperative Care of Esophagectomy | unknown | Phase 3 | 100 | Fudan UniversityOTHER | 0 | Sep 6, 2017 | clinicaltrials |
| NCT01950442 | Balloon Dilation to Permit Complete Endoscopic Ultrasound Staging in Esophageal Cancer(CT0046) | completed | N/A | 41 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Sep 1, 2017 | clinicaltrials |
| NCT01740375 | Role of Esophagectomy in Complete Responders to CCRT(ESOPRESSO) | terminated | Phase 3 | 486 | Asan Medical CenterOTHER | 1 | Aug 29, 2017 | clinicaltrials |
| NCT00987857 | Endoscopy Every 2 Years or Only as Needed in Monitoring Patients With Barrett Esophagus | unknown | N/A | 3,400 | Gloucestershire Hospitals NHS Foundation TrustOTHER | 1 | Aug 22, 2017 | clinicaltrials |
| NCT00394433 | Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer | completed | Phase 2 | 38 | Dana-Farber Cancer InstituteOTHER | 1 | Aug 1, 2017 | clinicaltrials |
| NCT01551589 | Involved Field Irradiation (IFI) Versus Elective Nodal Irradiation (ENI) for Esophageal Cancer | completed | N/A | 220 | Chengya ChouOTHER | 1 | Jul 26, 2017 | clinicaltrials |
| NCT03224221 | Apatinib Combined With Chemotherapy for Esophageal Squamous Cell Cancer After the Failure of Standard Treatment | unknown | Phase 2 | 189 | The First Affiliated Hospital of Anhui Medical UniversityOTHER | 1 | Jul 21, 2017 | clinicaltrials |
| NCT02959385 | A Phase II Trial to Compare Efficacy and Safety of CRT VS Neo-CRT in Patients Who Achieved CCR for Esophageal Cancer | unknown | Phase 2 | 40 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Jul 18, 2017 | clinicaltrials |
| NCT03216135 | Microbiome Involvement With Barrett's Esophagus and Progression to Esophageal Adenocarcinoma | unknown | — | 50 | Ochsner Health SystemOTHER | 1 | Jul 13, 2017 | clinicaltrials |
| NCT02465892 | Pillars4Life Trial(Pillars4Life) | completed | N/A | 284 | Duke UniversityOTHER | 1 | Jul 2, 2017 | clinicaltrials |
| NCT01807546 | Oral Rigosertib for Squamous Cell Carcinoma | completed | Phase 2 | 64 | Traws Pharma, Inc.INDUSTRY | 1 | Jun 26, 2017 | clinicaltrials |
| NCT02913066 | S-1 IMRT Versus S-1 and Cisplatin Concurrent IMRT in Inoperable Esophageal Squamous Cell Carcinoma | unknown | Phase 2 | 88 | Mianyang Central HospitalOTHER | 1 | Jun 16, 2017 | clinicaltrials |
| NCT03176680 | The Effects on Major Organ Complications on Esophagectomy of New Anesthetic ERAS Strategy: a Prospective Investigation(ERAS) | unknown | N/A | 120 | National Taiwan University HospitalOTHER | 1 | Jun 5, 2017 | clinicaltrials |
| NCT01231399 | Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer | completed | Phase 1 / Phase 2 | 6 | City of Hope Medical CenterOTHER | 1 | May 31, 2017 | clinicaltrials |
| NCT02273713 | The Addition of Nab-paclitaxel (Abraxane) to First Line Treatment of Metastasized Oesophagogastric Carcinoma (ACTION)(ACTION) | completed | Phase 1 / Phase 2 | 154 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | May 31, 2017 | clinicaltrials |
| NCT00376987 | Zinc Supplements in Lowering Cadmium Levels in Smokers | completed | Phase 2 | 61 | Wake Forest University Health SciencesOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT00534001 | Bupropion in Helping Adults Stop Smoking | completed | Phase 2 | 95 | Roswell Park Cancer InstituteOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT00654160 | Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer | completed | Phase 1 | 7 | Mayo ClinicOTHER | 1 | May 25, 2017 | clinicaltrials |
| NCT00836992 | Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer | completed | — | 144 | Mayo ClinicOTHER | 1 | May 24, 2017 | clinicaltrials |
| NCT00670553 | A Phase I Study of LBH589 (Panobinostat) in Combination With External Beam Radiotherapy for the Treatment of Prostate Cancer, Esophageal Cancer and Head and Neck Cancer | completed | Phase 1 | 7 | Novartis PharmaceuticalsINDUSTRY | 1 | May 17, 2017 | clinicaltrials |
| NCT01243619 | FLT PET/CT for Staging, Target Definition and Assessment of Response to Therapy in Patients With Esophageal Cancer | completed | N/A | 5 | Dana-Farber Cancer InstituteOTHER | 1 | May 17, 2017 | clinicaltrials |
| NCT02547610 | MR/PET in the Evaluation of Patients With Esophageal Cancer | unknown | — | 80 | National Taiwan University HospitalOTHER | 1 | May 16, 2017 | clinicaltrials |
| NCT02100189 | Esophageal Cytology With FISH in Detecting Esophageal Cancer | completed | N/A | 50 | OHSU Knight Cancer InstituteOTHER | 1 | May 11, 2017 | clinicaltrials |
| NCT00400114 | Sutent Following Chemotherapy, Radiation and Surgery For Resectable Esophageal Cancer | completed | Phase 2 | 36 | University Health Network, TorontoOTHER | 1 | May 8, 2017 | clinicaltrials |
| NCT00160875 | Pre-operative Chemo (CPT11, Cisplatin), Radiotherapy, Plus Surgery for Resectable Esophageal Cancer | completed | Phase 2 / Phase 3 | 54 | University Health Network, TorontoOTHER | 1 | May 4, 2017 | clinicaltrials |
| NCT00816634 | Efficacy Comparison Study of Combination Regimens to Treat Advanced Esophageal Squamous Cell Carcinoma(XP versus XT) | unknown | Phase 2 | 94 | Samsung Medical CenterOTHER | 1 | May 1, 2017 | clinicaltrials |
| NCT03120572 | Effect of Concurrent Chemoradiation Therapy on Respiratory Muscle Performance, Lung Function and Functional Capacity in Patients With Local Esophagus Cancer | completed | — | 45 | Mackay Memorial HospitalOTHER | 1 | Apr 19, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Jan 23, 2018source: clinicaltrials